Physician profile
Kurt Hu
NPI 1699114157
$55,306.97
in general payments reported to CMS, 2019-2025
17 companies · $28K in 2025
The $28K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,230 · 2020: $14.85 · 2021: $243 · 2022: $2,586 · 2023: $10K · 2024: $12K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Consulting Fee: $20K · Food and Beverage: $2,732 · Travel and Lodging: $2,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,881.00 |
| Consulting Fee | $20,190.00 |
| Food and Beverage | $2,732.41 |
| Travel and Lodging | $2,429.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $39,001.45 | 2019-2025 | |
| Pulmonx Corporation | $12,169.23 | 2022-2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Astrazeneca Pharmaceuticals LP | $1,589.68 | 2024-2025 | Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,223.26 | 2019-2025 | Nucala |
| Genentech USA, INC. | $251.26 | 2019-2022 | |
| Astellas Pharma US INC | $206.93 | 2019 | |
| Insmed, INC. | $191.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $122.15 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $103.07 | 2019 | |
| Intuitive Surgical, INC. | $103.03 | 2023 | Da Vinci Surgical System |
| Janssen Pharmaceuticals, INC | $101.03 | 2019 | |
| Alexion Pharmaceuticals, INC. | $96.39 | 2019 | |
| Verona Pharma, INC. | $44.17 | 2025 | Ohtuvayre |
| Cook Medical LLC | $39.52 | 2024-2025 | Wayne, Blue Rhino |
| Electromed, INC. | $37.39 | 2022-2023 | Smartvest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $14.85 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.